Adrienne Farid - Jun 9, 2025 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Role
Chief Operations Officer
Signature
/s/ Douglas Carr, Attorney-in-Fact
Stock symbol
IPSC
Transactions as of
Jun 9, 2025
Transactions value $
-$343
Form type
4
Date filed
6/11/2025, 05:05 PM
Previous filing
May 7, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Farid Adrienne Chief Operations Officer C/O CENTURY THERAPEUTICS, INC., 25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA /s/ Douglas Carr, Attorney-in-Fact 2025-06-11 0001867310

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IPSC Common Stock Sale -$343 -552 -0.22% $0.62 250K Jun 9, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.